AU2014351802B2 - Mitochondria-targeted dicarbonyl sequestering compounds - Google Patents

Mitochondria-targeted dicarbonyl sequestering compounds Download PDF

Info

Publication number
AU2014351802B2
AU2014351802B2 AU2014351802A AU2014351802A AU2014351802B2 AU 2014351802 B2 AU2014351802 B2 AU 2014351802B2 AU 2014351802 A AU2014351802 A AU 2014351802A AU 2014351802 A AU2014351802 A AU 2014351802A AU 2014351802 B2 AU2014351802 B2 AU 2014351802B2
Authority
AU
Australia
Prior art keywords
formula
alkylene
alkyl
compound
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2014351802A
Other languages
English (en)
Other versions
AU2014351802A1 (en
Inventor
Richard Charles Hartley
Michael Patrick Murphy
Robin Andrew James Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Kingdom Research and Innovation
Original Assignee
United Kingdom Research and Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Kingdom Research and Innovation filed Critical United Kingdom Research and Innovation
Publication of AU2014351802A1 publication Critical patent/AU2014351802A1/en
Assigned to UNITED KINGDOM RESEARCH AND INNOVATION reassignment UNITED KINGDOM RESEARCH AND INNOVATION Request for Assignment Assignors: MEDICAL RESEARCH COUNCIL
Application granted granted Critical
Publication of AU2014351802B2 publication Critical patent/AU2014351802B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Dentistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AU2014351802A 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds Ceased AU2014351802B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1320636.2A GB201320636D0 (en) 2013-11-22 2013-11-22 Compounds
GB1320636.2 2013-11-22
PCT/EP2014/075323 WO2015075200A1 (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Publications (2)

Publication Number Publication Date
AU2014351802A1 AU2014351802A1 (en) 2016-05-26
AU2014351802B2 true AU2014351802B2 (en) 2019-10-03

Family

ID=49918047

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014351802A Ceased AU2014351802B2 (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Country Status (12)

Country Link
US (1) US9963474B2 (enExample)
EP (2) EP3623375A1 (enExample)
JP (1) JP6661533B2 (enExample)
CN (1) CN105873936B (enExample)
AU (1) AU2014351802B2 (enExample)
CA (1) CA2931000A1 (enExample)
ES (1) ES2802123T3 (enExample)
GB (1) GB201320636D0 (enExample)
HK (1) HK1226079A1 (enExample)
SG (2) SG10201807904RA (enExample)
WO (1) WO2015075200A1 (enExample)
ZA (1) ZA201603129B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503280A (ja) * 2016-12-29 2020-01-30 ウニヴェルシダージ ド ポルトＵｎｉｖｅｒｓｉｄａｄｅ Ｄｏ Ｐｏｒｔｏ ヒドロキシ安息香酸誘導体、その方法および使用
JP6985730B2 (ja) * 2017-11-17 2021-12-22 株式会社日立ハイテクサイエンス 試料分析システム、表示方法及び試料分析方法
KR101920902B1 (ko) * 2017-12-27 2018-11-21 전남대학교 산학협력단 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도
WO2020036329A1 (ko) * 2018-08-16 2020-02-20 숙명여자대학교산학협력단 미토콘드리아 내 nad(p)h 검출을 위한 형광 프로브 및 이를 이용한 검출방법
AU2020212612B2 (en) * 2019-01-25 2025-07-31 Naji Abumrad Triphenylphosphonium-tethered salicylamine derivatives
EP3914077A4 (en) * 2019-01-25 2022-11-30 Vanderbilt University MITOCHONDRIAL TARGETING ISOKETAL/ISOLEVUGLANDIN SCAVENGERS
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2021154877A1 (en) * 2020-01-27 2021-08-05 Vanderbilt University Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB926998A (en) * 1960-04-25 1963-05-22 Ici Ltd New water-soluble azo dyestuffs containing phosphonium groups
JPS52806A (en) 1975-02-20 1977-01-06 Dai Ichi Kogyo Seiyaku Co Ltd Preparation of ester
JPS6029391B2 (ja) 1976-02-04 1985-07-10 富士写真フイルム株式会社 ベンゾトリアゾ−ル化合物
FR2776289B1 (fr) * 1998-03-20 2001-02-02 Oreal Composition de teinture d'oxydation contenant un coupleur cationique, procedes de teinture, nouveaux coupleurs cationiques
FR2776290B1 (fr) * 1998-03-20 2001-08-10 Oreal Nouveaux composes cationiques, leur utilisation comme coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
FR2788520B1 (fr) * 1999-01-19 2003-02-28 Oreal Nouveaux colorants mono-benzeniques cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
WO2002058659A1 (en) * 2001-01-23 2002-08-01 P&G-Clairol, Inc. Couplers for oxidative coloration of hair
AU2003258664A1 (en) * 2002-09-02 2004-03-19 Ciba Specialty Chemicals Holding Inc. Method of colouring porous material
JPWO2006059423A1 (ja) * 2004-12-02 2008-06-05 独立行政法人科学技術振興機構 過興奮性の細胞傷害によって生じる疾患を治療するための薬剤および方法
US7956193B2 (en) * 2007-05-04 2011-06-07 University Of South Florida Intramolecular C-H amination with sulfonyl azides
CA2699794C (en) 2007-09-10 2016-07-19 University Of Massachusetts Mitochondria-targeted anti-tumor agents
FR2984321A1 (fr) * 2011-12-16 2013-06-21 Oreal Paraphenylenediamines cationiques, composition comprenant au moins de tels composes, procede de mise en oeuvre et utilisation
CN102617467A (zh) * 2012-02-21 2012-08-01 大连理工大学 一种检测一氧化氮的超高灵敏荧光探针
FR2996552B1 (fr) * 2012-08-17 2016-10-14 Oreal Composition tinctoriale comprenant un derive o-alkyle substitue de meta-phenylenediamine cationique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PAMELA BOON LI PUN ET AL, "Pathological Significance of Mitochondrial Glycation", INTERNATIONAL JOURNAL OF CELL BIOLOGY, (2012-01-01), vol. 19, no. 3, doi:10.1073/pnas.95.10.5533, ISSN 1687-8876, pages 231 - 13 *

Also Published As

Publication number Publication date
CA2931000A1 (en) 2015-05-28
EP3623375A1 (en) 2020-03-18
WO2015075200A1 (en) 2015-05-28
CN105873936A (zh) 2016-08-17
GB201320636D0 (en) 2014-01-08
CN105873936B (zh) 2018-09-14
ZA201603129B (en) 2018-12-19
US20160289252A1 (en) 2016-10-06
AU2014351802A1 (en) 2016-05-26
ES2802123T3 (es) 2021-01-15
NZ719705A (en) 2021-09-24
EP3071582A1 (en) 2016-09-28
EP3071582B1 (en) 2020-04-29
HK1226079A1 (zh) 2017-09-22
US9963474B2 (en) 2018-05-08
JP6661533B2 (ja) 2020-03-11
SG10201807904RA (en) 2018-10-30
JP2017504561A (ja) 2017-02-09
SG11201603485TA (en) 2016-05-30

Similar Documents

Publication Publication Date Title
US9963474B2 (en) Mitochondria-targeted dicarbonyl sequestering compounds
CN102471248B (zh) 用于递送1,3-丙二磺酸的方法、化合物和组合物
CN109152933B (zh) 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途
ES2732230T3 (es) Compuestos que anulan el punto de control G2 del ciclo celular para una utilización en el tratamiento del cáncer
ES2731657T3 (es) Derivados de ácido sulfónico, ácido fosfónico y ácido carboxílico que contienen amonio y su uso médico
JP2009521408A (ja) Ｃｄｃ２様キナーゼ（ＣＬＫ）のモジュレータおよびその使用方法
CN101501054A (zh) 氨基磷酸酯烷化剂前体药物
IL296586A (en) Cyclophilin inhibitors and their uses
JP2020536853A (ja) 転写因子ｓａｌｌ４の小分子阻害およびその使用
JP2019523260A (ja) キラルペプチド
JP2022078213A (ja) クレアチンプロドラッグ、その組成物、及びその使用方法
JP2026048875A (ja) インスリン耐性における使用方法のための治療化合物
US10975069B2 (en) Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof
JP2026041735A (ja) 治療用金属錯体およびリガンドならびにその作成および使用の方法
US20220401435A1 (en) Mrgprx2 antagonist for the treatment of pseudo allergic reactions
CN111417620A (zh) 肌酸前药、其组合物以及使用方法
ES2858551T3 (es) Antagonistas del receptor de tromboxano
AU2019351731A1 (en) Spak kinase inhibitors as neuroprotective agents
TWI741979B (zh) 磷酸肌酸類似物前藥、其組成物及用途
NZ719705B2 (en) Mitochondria-targeted dicarbonyl sequestering compounds
ES2222988T3 (es) Formas de sal especificas de derivados de trifeniletileno como moduladores selectivos de los receptores de estrogenos.
EP4221753A1 (en) Compositions and methods of treating kidney disease and fibrosis
ES2398268T3 (es) Derivados de fenantrolina triplemente sustituidos para el tratamiento de enfermedades o estados neurodegenerativos o hematológicos, o cáncer

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: UNITED KINGDOM RESEARCH AND INNOVATION

Free format text: FORMER APPLICANT(S): MEDICAL RESEARCH COUNCIL

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired